Mutation analysis in glycogen storage disease type III patients in the Netherlands: Novel genotype-phenotype relationships and five novel mutations in the AGL gene

JIMD Reports

Volumn 7, Issue , 2013, Pages 19-26

  Sentner, Christiaan P ^a   Vos, Yvonne J ^b   Niezen Koning, Klary N ^a   Mol, Bart ^b   Smit, G Peter A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Distal myopathy; Full gene sequencing; Glycogen storage disease type; Type IIIa; Type IIIb

Indexed keywords

EID: 84904357579     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2012_134     Document Type: Chapter

References (24)

1. Akazawa H, Kuroda T, Kim S, Mito H, Kojo T, Shimada K (1997) Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy. Eur Heart J 18:532–533
2. Bao Y, Dawson TL Jr, Chen YT (1996) Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5’ flanking region. Genomics 38:155–165
3. Bao Y, Yang BZ, Dawson TL Jr, Chen YT (1997) Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific iso-forms. Gene 15:389–398
4. Cheng A, Zhang M, Okubo M, Omichi K, Saltiel AR (2009) Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions. Hum Mol Genet 18:2045–2052
5. Ding JH, De Barsy T, Brown BI, Coleman RA, Chen YT (1990) Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 116:95–100
6. Goldstein JL, Austin SL, Boyette K, Kanaly A, Veerapandiyan A, Rehder C, Kishnani PS, Bali DS (2010) Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with glycogen storage disease type III. Genet Med 12:424–430
7. Haagsma EB, Smit GPA, Niezen-Koning KE, Gouw AS, Meerman L, Slooff MJ (1997) Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology 25:537–540
8. Hayes VM, Wu Y, Osinga J, Mulder IM, van der Vlies P, Elfferich P, Buys CH, Hofstra RM (1999) Improvements in gel composition and electrophoretic conditions for broad-range mutation analysis by denaturing gradient gel electrophoresis. Nucleic Acids Res 27: e29
9. Hobson-Webb LD, Austin SL, Bali DS, Kishnani PS (2010) The electrodiagnostic characteristics of glycogen storage disease type III. Genet Med 12:440–445
10. Lam CW, Lee AT, Lam YY, Wong TW, Mak TW, Fung WC, Chan KC, Ho CS, Tong SF (2004) DNA-based subtyping of glycogen storage disease type III: mutation and haplotype analysis of the AGL gene in Chinese. Mol Genet Metab 83:271–275
11. Lee PJ, Deanfield JE, Burch M, Baig K, McKenna WJ, Leonard JV (1997) Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol 79:834–838
12. Liu W, Madsen NB, Braun C, Withers SG (1991) Reassessment of the catalytic mechanism of glycogen debranching enzyme. Biochemistry 30:1419–1424
13. Lucchiari S, Pagliarani S, Salani S, Filocamo M, Di Rocco M, Melis D, Rodolico C, Musumeci O, Toscano A, Bresolin N, Comi GP (2006) Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL. Hum Mutat 27:600–601
14. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1225
15. Newgard CB, Hwang PK, Fletterick RJ (1989) The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol 24:69–99
16. Okubo M, Horinishi A, Nakamura N, Aoyama Y, Hashimoto M, Endo Y, Murase T (1998) A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12→G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. Hum Genet 102:1–5
17. Santer R, Kinner M, Steuerwald U, Kjaergaard S, Skovby F, Simonsen H, Shaiu WL, Chen YT, Schneppenheim R, Schaub J (2001) Molecular genetic basis and prevalence of glycogen storage disease type IIIa in the Faroe Islands. Eur J Hum Genet 9:388–391
18. Shaiu WL, Kishnani PS, Shen J, Liu HM, Chen YT (2000) Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease. Mol Genet Metab 69:16–23
19. Shen J, Bao Y, Liu HM, Lee PJ, Leonard JV, Chen YT (1996) Mutations in Exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 98:352–357
20. Shen J, Bao Y, Chen YT (1997) A nonsense mutation due to a single base insertion in the 3'-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa. Hum Mutat 9:37–40
21. Shen JJ, Chen YT (2002) Molecular characterization of glycogen storage disease type III. Curr Mol Med 2:167–175
22. Smit GPA, Rake JP, Akman HO, DiMauro S (2006) The glycogen storage diseases and related disorders. In: Fernandes J, Saudubray J-M, van den Berghe G, Walter JH (eds) Inborn metabolic diseases: diagnosis and treatment. Springer Medizin Verlag, Heidelberg, pp 103–116
23. Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4:95–102
24. Yang-Feng TL, Zheng K, Yu J, Yang BZ, Chen YT, Kao FT (1992) Assignment of the human glycogen debrancher gene to chromosome 1p22. Genomics 13:931–934